• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

LGE for Risk Stratification in Primary Prevention in Children With HCM.

作者信息

Petryka-Mazurkiewicz Joanna, Ziolkowska Lidia, Kowalczyk-Domagala Monika, Mazurkiewicz Lukasz, Boruc Agnieszka, Spiewak Mateusz, Misko Jolanta, Bieganowska Katarzyna, Marczak Magdalena, Brzezinska-Rajszys Grazyna

出版信息

JACC Cardiovasc Imaging. 2020 Dec;13(12):2684-2686. doi: 10.1016/j.jcmg.2020.06.009. Epub 2020 Jul 29.

DOI:10.1016/j.jcmg.2020.06.009
PMID:32739367
Abstract
摘要

相似文献

1
LGE for Risk Stratification in Primary Prevention in Children With HCM.心脏磁共振延迟强化成像用于肥厚型心肌病患儿一级预防中的风险分层
JACC Cardiovasc Imaging. 2020 Dec;13(12):2684-2686. doi: 10.1016/j.jcmg.2020.06.009. Epub 2020 Jul 29.
2
Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.与T1 mapping相比，定量扩散加权磁共振成像在肥厚型心肌病心肌纤维化评估中的应用
Int J Cardiovasc Imaging. 2016 Aug;32(8):1289-97. doi: 10.1007/s10554-016-0909-x. Epub 2016 May 19.
3
Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.肥厚型心肌病延迟钆增强的定量分析：钆布醇与钆喷酸葡胺在心肌纤维化诊断效能上的比较
Int J Cardiovasc Imaging. 2017 Aug;33(8):1191-1200. doi: 10.1007/s10554-017-1101-7. Epub 2017 Mar 13.
4
Refining the Prognostic Value of LGE in Hypertrophic Cardiomyopathy: Presence, Extent, and Location-What's Next?优化肥厚型心肌病中延迟强化成像的预后价值：存在、范围及位置——下一步是什么？
JACC Cardiovasc Imaging. 2023 Sep;16(9):1178-1180. doi: 10.1016/j.jcmg.2023.04.002. Epub 2023 May 17.
5
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.心脏磁共振成像在肥厚型心肌病患者心源性猝死风险分层中的价值及延迟钆增强分布情况
J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9.
6
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.应用三维斑点追踪超声心动图研究心肌整体和局部力学与肥厚型心肌病心肌肥厚和纤维化的关系。
Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25.
7
High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.高心电图风险评分可预测年轻肥厚型心肌病患者磁共振成像上的晚期钆增强。
Pediatr Cardiol. 2021 Mar;42(3):492-500. doi: 10.1007/s00246-020-02506-9. Epub 2021 Jan 30.
8
Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.用于检测小儿肥厚型心肌病中心肌纤维化的新型心脏磁共振特征追踪（CMR-FT）分析
Pediatr Cardiol. 2016 Apr;37(4):663-73. doi: 10.1007/s00246-015-1329-8. Epub 2016 Jan 30.
9
Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.无创评估梗阻性肥厚型心肌病患者的心肌纤维化。
Heart. 2014 Apr;100(8):631-8. doi: 10.1136/heartjnl-2013-304923. Epub 2013 Dec 24.
10
Diffusion-weighted imaging in hypertrophic cardiomyopathy: association with high T2-weighted signal intensity in addition to late gadolinium enhancement.肥厚型心肌病的扩散加权成像：除延迟钆增强外，还与高T2加权信号强度相关。
Int J Cardiovasc Imaging. 2020 Nov;36(11):2229-2238. doi: 10.1007/s10554-020-01933-2. Epub 2020 Jul 14.

引用本文的文献

1
Role of late gadolinium enhancement in the risk stratification of pediatric hypertrophic cardiomyopathy: based on a Chinese cohort.延迟钆增强在儿童肥厚型心肌病危险分层中的作用：基于中国队列研究
Lancet Reg Health West Pac. 2025 May 15;58:101573. doi: 10.1016/j.lanwpc.2025.101573. eCollection 2025 May.
2
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
3
Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management.
小儿肥厚型心肌病的当代综述：检测与管理见解
Front Cardiovasc Med. 2024 Jan 4;10:1277041. doi: 10.3389/fcvm.2023.1277041. eCollection 2023.
4
Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making.PRIMaCY 儿童肥厚型心肌病猝死风险预测模型的性能：对植入式心脏复律除颤器决策的影响。
Europace. 2023 Nov 2;25(11). doi: 10.1093/europace/euad330.
5
Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity.肥厚型心肌病患儿的风险分层分析及心源性猝死预防：困境与明晰
Heart Rhythm O2. 2023 Jun 20;4(8):506-516. doi: 10.1016/j.hroo.2023.06.007. eCollection 2023 Aug.
6
Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort.延迟钆增强磁共振成像在印度队列肥厚型心肌病患者中的效用
Indian Heart J. 2023 Sep-Oct;75(5):383-385. doi: 10.1016/j.ihj.2023.08.001. Epub 2023 Aug 9.
7
What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?小儿肥厚型心肌病中，哪些表型方面决定心脏性猝死风险？
J Cardiovasc Dev Dis. 2022 Apr 21;9(5):124. doi: 10.3390/jcdd9050124.
8
Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying Pathogenic Variants.携带致病性变异的三个家族中左心室致密化不全心肌病和心动过缓的临床表现
Genes (Basel). 2022 Mar 8;13(3):477. doi: 10.3390/genes13030477.
9
Imaging Features of Pediatric Left Ventricular Noncompaction Cardiomyopathy in Echocardiography and Cardiovascular Magnetic Resonance.小儿左心室心肌致密化不全心肌病的超声心动图及心血管磁共振成像特征
J Cardiovasc Dev Dis. 2022 Mar 5;9(3):77. doi: 10.3390/jcdd9030077.
10
Ventricular arrhythmia management in patients with genetic cardiomyopathies.遗传性心肌病患者的室性心律失常管理
Heart Rhythm O2. 2021 Dec 17;2(6Part B):819-831. doi: 10.1016/j.hroo.2021.10.009. eCollection 2021 Dec.